NUS Links:
Home › News & Events › News & Media
11 October 2023
This study, co-led by A/Prof Takaomi Sanda and A/Prof Allen Yeoh, delves into T-cell acute lymphoblastic leukemia (T-ALL...
The PI3K/AKT/mTOR (PAM) signaling pathway is crucial in regulating cell survival, growth, and the cell cycle. Its comple...
12 September 2023
N2CR had the honour of having Dr Sophia Adamia, from the Beth Israel Deaconess Medical Center in Boston, visit us on 5 S...
9 September 2023
On 4th and 5th September 2023, N2CR had the honour of holding the NUS-Kanagawa Symposium 2023, jointly with CSI Singap...
15 August 2023
Pancreatic cancer is a devastating illness with a poor five-year survival rate. A team of researchers, which includes A/...
5-Fluorouracil (5-FU) is a common chemotherapy drug widely used around the world to treat cancer but development of resi...
12 July 2023
A team of researchers, led by A/Prof Gautam Sethi from N2CR, conducted a study investigating the therapeutic possibiliti...
5 July 2023
Osteosarcoma, the most common bone cancer, usually affects children or adolescents during their pubertal growth spurt. P...
Epstein-Barr virus (EBV)-associated smooth muscle tumours (EBV-SMTs) are rare tumours that can arise in immunosuppressed...
